|
⚲
|
| Keyboard |
| O'Keeffe Charles B
✚
|
|
|---|---|
| CIK # | 0001378656 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001378656] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catalyst Pharmaceuticals Inc | |
| O'Keeffe Charles B |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-02-14 | Option exercise | 4,000 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-02-14 | Option exercise | 4,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-27 | Option exercise | 1,333 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-27 | Option exercise | 1,333 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-10 | Option exercise | 40,000 | $4.01 | 160,400 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-12-10 | Option exercise | 40,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-09 | Option exercise | 1,413 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-09 | Option exercise | 1,413 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-11-21 | Grant | 23,248 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted stock units · derivative
|
2024-11-21 | Grant | 2,841 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-02-15 | Option exercise | 4,000 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-02-15 | Option exercise | 4,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-01-02 | Option exercise | 60,000 | $1.13 | 67,800 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-01-02 | Option exercise | 60,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2023-12-27 | Option exercise | 1,333 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2023-12-27 | Option exercise | 1,333 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted stock units · derivative
|
2023-12-08 | Grant | 4,240 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2023-12-08 | Grant | 29,524 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2023-02-15 | Option exercise | 4,000 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2023-02-15 | Option exercise | 4,000 | $0.00 | |
| showing 20 of 86 most recent transactions | |||||